Search results
Results From The WOW.Com Content Network
42–45 Luz Church Road, Mylapore, Chennai – 600004 ... Amrutanjan Healthcare Limited is an Indian pharmaceutical company headquartered in ... Pvt Ltd. ISBN 81 ...
Dr. Mehta's Hospital is one of the oldest private medical institutions in Chennai, Tamil Nadu, India founded in 1933. It is a multi-speciality tertiary care hospital with over 500 beds and two campuses located in Chetpet and Velappanchavadi .
Rapid advances in the H&PC sector led to the company being listed with the BSE and the NSE in 2005. In 2007, VVS Pharma, a sister company which operated in the pharmaceutical and health-care sector merged with Vivimed Labs. The Specialty Chemicals Division was headed by Santosh Varalwar and the Health Care division was headed by Sandeep Varalwar.
Sun Pharmaceutical Industries Ltd. was established by Dilip Shanghvi in 1983 in Calcutta, West Bengal with five psychiatry products and a two-person marketing team. Today it is ranked number one in share of prescriptions with 12 classes of doctors in India and a market leader in Psychiatry, Neurology, Cardiology, Orthopaedics, Gastroenterology, Nephrology, Diabetology, Dermatology, Urology ...
Orchid Chemicals & Pharmaceuticals Limited is an Indian pharmaceutical company based in Chennai, founded on 1 July 1992, by Kailasam Raghavendra Rao, an alumnus of IIM Ahmedabad (PGP '79) . As of 2007, it was among the top fortune 500 Indian companies by market capitalization .
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. [ 4 ] [ 5 ] The company's product portfolio includes prescription medicines and vaccines .
The TTK Group is an Indian business conglomerate with a presence across several segments of industry including consumer durables, pharmaceuticals and supplements, bio-medical devices, maps and atlases, consular visa services, virtual assistant services and health care services.
Valeant Pharmaceuticals (NYS: VRX) announced plans on Monday to acquire Medicis Pharmaceutical (NYS: MRX) for $2.6 billion. The deal values Medicis at a 39% premium to Friday's closing price.